Lumiata, a San Francisco-based AI-powered predictive analytics startup, has raised $10 million in Series B financing led by Intel Capital. Existing investors Blue Cross Blue Shield Venture Partners, Sandbox Industries, and Khosla Ventures also participated in the round. The company has raised $20 million to date.

The Lumiata Medical Graph is comprised of more than 260 million data points, 4TB of structured and unstructured medical knowledge and 35,000 hours of physician review, says the company. The graph utilizes data types ranging from claims and EHR data to laboratory results and sensor readings, developed against a data repository of more than 60 million patient lives. Lumiata’s technology is utilized by Universal American, Google, and a major BlueCross plan.

[Image courtesy: Lumiata]